Emerging Growth Capital Investors offers retail and wholesale investors access to a fund of Australian small cap listed biotechnology and life science companies.
Fixed income
Emerging market debt offers good strategic opportunities says Aviva Investors’ Aaron Grehan
Asset allocators should review their biases of emerging market debt as a tactical investment of higher-yielding, lower-quality assets, says expert.
Meredith BoothNovember 10, 2021
